Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Brain Protein May Be Early Indicator of Alzheimer’s Disease

By LabMedica International staff writers
Posted on 08 Feb 2012
Recent research has shown that specific proteins found in exosomes may be indicators of advanced Alzheimer’s disease (AD).

The scientists discovered that exosomes containing tau and other proteins are an indicator of AD. More...
Exosomes can be found in the cerebral spinal column and examined through a spinal tap. High levels of tau found in the exosome are an indicator of advanced stages of AD.

The researchers from MassBay Community College (Wellesley Hills, MA, USA) successfully collaborated with biologic science counterparts from University of Massachusetts (UM)-Lowell (MA, USA) and Boston University (MA, USA) on experiments related to early detection of AD. The research was performed in MassBay’s biotechnology and environmental science labs.

According to Dr. Sudad Saman, an adjunct professor of STEM at MassBay, and researcher and author of the article, stated, “Often Alzheimer’s disease is detected in patients in its later stages, when the disease has become more apparent to loved ones. By discovering Alzheimer’s in patients earlier, they can start taking medications, even five years earlier can be beneficial to extending the life of the individual as well as delaying the degenerating effects of the disease.”

“This is extraordinary work being done here at MassBay,” said President John O'Donnell. “MassBay has long benefitted from world-class biotechnology and environmental science programs, and our elite professors continue to make important contributions to the world of science.”

“The result of our work may become revolutionary in diagnosing Alzheimer’s disease in its early onset,” concluded Dr. Sudad Saman. “We believe our discovery is quite significant.”

Related Links:

Boston University
MassBay Community College
University of Massachusetts-Lowell



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.